Paid Clinical Trials in Margate, FL
As of August 2026, 54 paid clinical trials are recruiting in Margate, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Margate offers studies at sites including Life Clinical Trials for conditions such as Atopic Dermatitis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE). Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Margate
Trials by drug in Margate
Filter results
Newly added in Margate
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
53 clinical trials
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Prospective Study to Assess a Diagnostic Aid for Cancer
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Top Research Study Locations in Margate
Researchers run research studies in Margate, FL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Life Clinical Trials | Lupus Nephritis, Overweight or Obesity, Plaque Psoriasis | 5 |
| D&H Cancer Research Center | Cancer Weight Loss, HER2-negative Breast Cancer Patients With Brain Metastases, Locally Advanced or Metastatic Solid Tumors | 3 |
| IVF Florida Reproductive Associates | Chaotic Aneuploidy, Complex Aneuploidy, Infertility (IVF Patients) | 3 |
| D&H Pompano Research Center | Diabetic Kidney Disease (DKD), Tophaceous Gout, Plasma Cell Myeloma Refractory | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| D&H National Research Center | Melanoma, Multiple Myeloma (MM), Non-small Cell Lung Cancer | 2 |
| D&H Pompano Research Center, LLC | Gout, Major Depressive Disorder | 2 |
| South Florida Clinical Research | Atherosclerotic Cardiovascular Disease, Obesity, Obesity or Overweight | 2 |
| Atlantic Medical Research | Ulcerative Colitis, Crohn's Disease | 2 |
| D&H Cancer Research Center LLC | COVID-19 Infection, Advanced Cancer, Advanced Solid Tumor | 2 |
| Life Clinical Trials - Colonial Drive - Margate | Rheumatoid Arthritis, Dry Eye Syndrome, Systemic Lupus Erythematosus | 2 |
| Arthritis & Rheumatology Center of South Florida | Rheumatoid Arthritis | 1 |
| Clinical Trial Site | Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer | 1 |
| D & H Cancer Research Center | IO-resistant sqNSCLC | 1 |
| D&H Cancer Research Center LLC - 1153 | Non Small Cell Lung Cancer | 1 |
| D&H Cancer Research Center, LLC | Metastatic Castration-Resistant Prostate Cancer | 1 |
| D&H National Research Centers - Cancer Research Center, LLC | Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma | 1 |
| D&H National Research Centers, LLC | Hepatocellular Carcinoma (HCC) | 1 |
| D&H Pompano Research Center LLC | Measles, Measles-Mumps-Rubella+Chickenpox Vaccine, Mumps | 1 |
| DH Cancer Research Center LLC | Primary Evans Syndrome (ES), Primary Immune Thrombocytopenia (ITP) | 1 |
| GSI Clinical Research, LLC | Alopecia Areata | 1 |
| GSI Clinical Research, LLC | Atopic Dermatitis | 1 |
| Gsi Clinical Research | Atopic Dermatitis, Eczema, Atopic | 1 |
| Life Clinical Trials - Margate - Colonial Drive | Immunoglobulin G4 Related Disease | 1 |
| Margate | Endometriosis, Uterine Fibroids | 1 |
Active & Upcoming Studies in Margate (2026)
Recruiting trials in Margate grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (13 active studies)
- A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma · Phase 1 · Shanghai Henlius Biotech
- Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma · Phase 1 · Shanghai Henlius Biotech
Diabetes & metabolic (6 active studies)
- Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH) · Phase 3 · Amgen
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity · Phase 3 · Amgen
Vaccines (2 active studies)
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age · Phase 3 · GlaxoSmithKline
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
Common conditions studied in Margate
- Atopic Dermatitis (3 active studies)
- Rheumatoid Arthritis (2 active studies)
- Systemic Lupus Erythematosus (2 active studies)
- Systemic Lupus Erythematosus (SLE) (2 active studies)
- Active Rheumatoid Arthritis (1 active study)
- Advanced Breast Cancer (1 active study)
Leading research sponsors in Margate
- AbbVie
- Pfizer
- Sanofi
- Shanghai Henlius Biotech
- Akero Therapeutics, Inc
Frequently asked questions
How many paid clinical trials are currently recruiting in Margate?
There are approximately 54 recruiting clinical trials in Margate, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Margate pay participants?
Most recruiting trials in Margate compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Margate?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Margate?
The most common conditions under active study in Margate include Atopic Dermatitis (3), Rheumatoid Arthritis (2), Systemic Lupus Erythematosus (2), Systemic Lupus Erythematosus (SLE) (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Margate?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Margate on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Margate?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Margate?
Recruiting research sites in Margate include Life Clinical Trials, D&H Cancer Research Center, IVF Florida Reproductive Associates, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Margate right now?
The largest active categories in Margate are Cancer & tumors (13), Diabetes & metabolic (6), Vaccines (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.